News

Filter

Current filters:

deCODE GeneticsDiabetes

201 to 210 of 95969 results

Positive preliminary results with Biodel's new insulin formulation in type 2 diabetes

Positive preliminary results with Biodel's new insulin formulation in type 2 diabetes

12-08-2014

Endocrine specialists Biodel has seen positive preliminary results from a Phase IIa trial of its insulin…

BIOD-531BiodelBiotechnologyDiabetesDiabetes mellitus type 2Endocrine systemHumalog MixHumulin RResearchUSA

Synta appoints Sanofi's Anne Whitaker as chief executive

Synta appoints Sanofi's Anne Whitaker as chief executive

12-08-2014

Coming from her position as president of Sanofi’s North American pharma division, Anne Whitaker has…

Anne WhitakerBoardroomBreast cancerElesclomolOncologyPharmaceuticalSafi R. BahcallSanofiSynta PharmaceuticalsUSA

uniQure acquires cardiology gene therapy firm InoCard

12-08-2014

Netherlands-based human gene therapy firm uniQure says it has acquired Germany’s InoCard GmbH, an innovative,…

BiotechnologyCardio-vascularGermanyInoCardMergers & AcquisitionsNetherlandsuniQure

Sanofi in $925 million deal to commercialize MannKind’s Afrezza

Sanofi in $925 million deal to commercialize MannKind’s Afrezza

11-08-2014

French pharma major Sanofi has entered into a worldwide exclusive licensing agreement with the USA’s…

AfrezzaDiabetesGlobalInsulin therapyLicensingMannKindPeptide hormonesPharmaceuticalSanofi

Positive new Ph III data with Novo Nordisk’s Xultophy

Positive new Ph III data with Novo Nordisk’s Xultophy

11-08-2014

Positive new pivotal Phase III data about Xultophy (insulin degludec/liraglutide), formerly known as…

DiabetesIDegLiraNovo NordiskPharmaceuticalResearchXultophy

Ukraine may face drugs shortage this year

Ukraine may face drugs shortage this year

11-08-2014

Ukraine plans to ban pharmaceutical imports from Russia, except 20 vital drugs, the analogues of which…

Markets & MarketingPharmaceuticalPoliticsPricingRussiaUkraine

Imatinib and sunitinib will continue to dominate patient share in GIST treatment

Imatinib and sunitinib will continue to dominate patient share in GIST treatment

11-08-2014

The treatment landscape of gastrointestinal stromal tumors (GIST) will not change dramatically through…

BayerGleevecGlivecMarkets & MarketingNovartisOncologyPfizerPharmaceuticalStivargaSutent

201 to 210 of 95969 results

Back to top